Addressing the unmet need of cognitive dysfunction in schizophrenia

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Wykes T, Reeder C. Brunner-Routledge, London 2005.
  2. Patel A, et al. Schizophr Bull 2006;32:776-85.
  3. Albert N, et al. Psychol Med 2019;49:1138-47.
  4. Østergaard Christensen T, et al. Acta Psychiatrica Scandinavica 2014;130:300-10.
  5. Glenthøj LB, et al. Trials 2015;16:25.
  6. Kambeitz-Ilankovic L, et al. Neurosci Biobehav Rev 2019;107:828-45.
  7. Wykes T, et al. Schizophr Res 2012;138:88-93.
  8. Davies G, Greenwood K. J Ment Health 2018; 1-11.
  9. Bowie CR, et al. Schizophr Res 2020;215:49-53
  10. https://www.circuitstherapyinfo.com
  11. Cella M, et al. J Exp Psychopathol 2019;10(2):1-9.
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country